Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA)

被引:9
|
作者
Klaas, Lioba [1 ]
Vier, Juliane [1 ]
Gentle, Ian E. [1 ]
Hacker, Georg [1 ]
Kirschnek, Susanne [1 ]
机构
[1] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, Fac Med, Freiburg, Germany
关键词
PROGRAMMED NECROSIS; DENDRITIC CELLS; NECROPTOSIS; PHOSPHORYLATION; APOPTOSIS; CASPASES; PROTEIN; DEGRADATION; ACTIVATION; INDUCTION;
D O I
10.1038/s41419-021-04286-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Regulated cell death frequently occurs upon infection by intracellular pathogens, and extent and regulation is often cell-type-specific. We aimed to identify the cell death-signaling pathways triggered in macrophages by infection with modified vaccinia virus Ankara (MVA), an attenuated strain of vaccinia virus used in vaccination. While most target cells seem to be protected by antiapoptotic proteins encoded in the MVA genome, macrophages die when infected with MVA. We targeted key signaling components of specific cell death-pathways and pattern recognition-pathways using genome editing and small molecule inhibitors in an in vitro murine macrophage differentiation model. Upon infection with MVA, we observed activation of mitochondrial and death-receptor-induced apoptosis-pathways as well as the necroptosis-pathway. Inhibition of individual pathways had a little protective effect but led to compensatory death through the other pathways. In the absence of mitochondrial apoptosis, autocrine/paracrine TNF-mediated apoptosis and, in the absence of caspase-activity, necroptosis occurred. TNF-induction depended on the signaling molecule STING, and MAVS and ZBP1 contributed to MVA-induced apoptosis. The mode of cell death had a substantial impact on the cytokine response of infected cells, indicating that the immunogenicity of a virus may depend not only on its PAMPs but also on its ability to modulate individual modalities of cell death. These findings provide insights into the diversity of cell death-pathways that an infection can trigger in professional immune cells and advance our understanding of the intracellular mechanisms that govern the immune response to a virus.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Modified Vaccinia Virus Ankara (MVA)-Mediated Transgene Engineering into Dendritic Cells Creates Potent Vaccines Against Melanoma
    Aravindaram, Kandan
    Wang, Pei-Hsueh
    Yu, Hsiu-Hui
    Chen, Yun-Hsiang
    Lan, Chun-Wen
    Yang, Ning-Sun
    MOLECULAR THERAPY, 2009, 17 : S211 - S211
  • [32] T cells from a high proportion of apparently naive cattle can be activated by modified vaccinia virus Ankara (MVA)
    Sandbulte, MR
    Platt, R
    Roth, JA
    VIRAL IMMUNOLOGY, 2004, 17 (01) : 39 - 49
  • [33] Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain
    Spehner, D
    Drillien, R
    Proamer, F
    Houssais-Pêcheur, C
    Zanta, MA
    Geist, M
    Dott, K
    Balloul, JM
    VIROLOGY, 2000, 273 (01) : 9 - 15
  • [34] Evaluation of the protective potential of a recombinant modified vaccinia virus Ankara (MVA) encoding rift valley fever virus (RVFV) glycoproteins in lambs
    Busquets, N.
    Lopez, E.
    Lorenzo, G.
    Abad, F. X.
    Galindo, I.
    Rivas, R.
    Solanes, D.
    Bensaid, A.
    Rodriguez, F.
    Gilbert, S. C.
    Domingo, M.
    Brun, A.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 239 - 239
  • [35] Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus ankara and vaccinia virus
    Chahroudi, Ann
    Garber, David A.
    ReeveS, Patrick
    Liu, Luzheng
    Kalman, Daniel
    Feinberg, Mark B.
    JOURNAL OF VIROLOGY, 2006, 80 (17) : 8469 - 8481
  • [36] STING (stimulator of interferon genes) is required for the induction of autophagy in conventional dendritic cells and macrophages in response to infection by modified vaccinia virus Ankara
    Wang, W.
    Parikh, T.
    Dai, P.
    Gammoh, N.
    Ganley, I.
    Kim, S.
    Vance, R.
    Virgin, H. W.
    Overholtzer, M.
    Shuman, S.
    Jiang, X.
    Deng, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S206 - S206
  • [37] Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine-Reply
    Hazra, Aniruddha
    Schneider, John A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (12):
  • [38] Human Monkeypox Virus Infection in the Immediate Period After Receiving Modified Vaccinia Ankara Vaccine
    Hazra, Aniruddha
    Rusie, Laura
    Hedberg, Trevor
    Schneider, John A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (20): : 2064 - 2067
  • [39] Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy
    Ueberla, Klaus
    Rosenwirth, Brigitte
    ten Haaft, Peter
    Heeney, Jonathan
    Sutter, Gerd
    Erfle, Volker
    JOURNAL OF MEDICAL PRIMATOLOGY, 2007, 36 (01) : 2 - 9
  • [40] Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)
    Chiam, Rachael
    Sharp, Emma
    Maan, Sushila
    Rao, Shujing
    Mertens, Peter
    Blacklaws, Barbara
    Davis-Poynter, Nick
    Wood, James
    Castillo-Olivares, Javier
    PLOS ONE, 2009, 4 (06):